Filing Flows

Filing Flows › Comparisons › HRMY vs ZYME

Harmony Biosciences Holdings vs Zymeworks: HRMY and ZYME compared

Harmony Biosciences Holdings is the larger company: $269M of revenue in its latest quarter (Q3 2026) against $256M for Zymeworks (Q3 2026). Zymeworks is growing faster (+829% against +12% a year earlier). Zymeworks is more profitable, with an operating margin of 69.2% against 20.2%.

Harmony Biosciences Holdings vs Zymeworks, latest quarterHarmony Biosciences Holdings vs Zymeworks, latest quarterHarmony Biosciences Holdings (HRMY)Zymeworks (ZYME)Revenue$269M$256MRevenue growth, Y/Y+12%+829%Operating margin20.2%69.2%Net margin17.9%67.7%

Where the money goes: HRMY and ZYME

Harmony Biosciences Holdings (HRMY) · Q3 2026

Harmony Biosciences Holdings, Q3 2026: revenue $269M (+12% year over year), operating margin 20.2%, net earnings $48.2M, operating cash flow $76.7M. The chart follows the revenue to costs, profit and cash.

Zymeworks (ZYME) · Q3 2026

Zymeworks, Q3 2026: revenue $256M (+829% year over year), operating margin 69.2%, net earnings $174M, operating cash flow −$24.0M. The chart follows the revenue to costs, profit and cash.

Zymeworks revenue by segment, Q3 2026Zymeworks revenue by segment, Q3 2026License and milestone revenue$250MRoyalty and other revenue$4.9MViatris collaboration agreement r…$1.5M
Harmony Biosciences Holdings (HRMY)Zymeworks (ZYME)
Latest quarterQ3 2026Q3 2026
Revenue$269M$256M
Revenue growth, Y/Y+12%+829%
Gross margin70.0%—
Operating margin20.2%69.2%
Net earnings$48.2M$174M
Net margin17.9%67.7%
Operating cash flow$76.7M−$24.0M
Market value—$1.9B
Analysts’ mean target—$41.50

Where the revenue comes from

Zymeworks

Questions

Which is bigger, Harmony Biosciences Holdings or Zymeworks?

Harmony Biosciences Holdings is the larger company: $269M of revenue in its latest quarter (Q3 2026) against $256M for Zymeworks (Q3 2026).

Is Harmony Biosciences Holdings or Zymeworks growing faster?

Zymeworks is growing faster (+829% against +12% a year earlier).

Which is more profitable, Harmony Biosciences Holdings or Zymeworks?

Zymeworks is more profitable, with an operating margin of 69.2% against 20.2%.

More: Harmony Biosciences Holdings earnings · how Harmony Biosciences Holdings makes money · Zymeworks earnings · how Zymeworks makes money

From the companies' latest 10-Q, 10-K or earnings release (10-Q filed Nov 4, 2026; 10-Q filed Nov 9, 2026). Fiscal quarters can end on different dates. Not investment advice.